SRI SAI SUBRAMANYAM CHALLA. EVALUATING THE EFFECTIVENESS OF RISK-BASED APPROACHES IN STREAMLINING THE REGULATORY APPROVAL PROCESS FOR NOVEL THERAPIES. Journal of Population Therapeutics and Clinical Pharmacology, [S. l.], v. 28, n. 2, p. 436–448, 2021. DOI: 10.53555/jptcp.v28i2.7421. Disponível em: https://www.jptcp.com/index.php/jptcp/article/view/7421. Acesso em: 8 oct. 2025.